Osteopore Ltd (OSX) - Net Assets

Latest as of June 2025: AU$-423.65K AUD ≈ $-299.76K USD

Based on the latest financial reports, Osteopore Ltd (OSX) has net assets worth AU$-423.65K AUD (≈ $-299.76K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$4.19 Million ≈ $2.97 Million USD) and total liabilities (AU$4.62 Million ≈ $3.27 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check OSX asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$-423.65K
% of Total Assets -10.11%
Annual Growth Rate N/A
5-Year Change -96.6%
10-Year Change N/A
Growth Volatility 95.26

Osteopore Ltd - Net Assets Trend (2016–2024)

This chart illustrates how Osteopore Ltd's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Osteopore Ltd for the complete picture of this company's asset base.

Annual Net Assets for Osteopore Ltd (2016–2024)

The table below shows the annual net assets of Osteopore Ltd from 2016 to 2024. For live valuation and market cap data, see Osteopore Ltd market capitalisation.

Year Net Assets Change
2024-12-31 AU$306.22K
≈ $216.67K
-29.21%
2023-12-31 AU$432.60K
≈ $306.09K
-79.47%
2022-12-31 AU$2.11 Million
≈ $1.49 Million
-60.79%
2021-12-31 AU$5.37 Million
≈ $3.80 Million
-40.28%
2020-12-31 AU$9.00 Million
≈ $6.37 Million
+203.18%
2019-12-31 AU$2.97 Million
≈ $2.10 Million
-29.90%
2018-12-31 AU$4.23 Million
≈ $3.00 Million
+330.64%
2017-12-31 AU$-1.84 Million
≈ $-1.30 Million
-35.31%
2016-12-31 AU$-1.36 Million
≈ $-959.71K
--

Equity Component Analysis

This analysis shows how different components contribute to Osteopore Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1560107900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock AU$32.60 Million 10645.98%
Other Comprehensive Income AU$-14.23 Million -4646.28%
Total Equity AU$306.22K 100.00%

Osteopore Ltd Competitors by Market Cap

The table below lists competitors of Osteopore Ltd ranked by their market capitalization.

Company Market Cap
M N C Wireless Bhd
KLSE:0103
$2.39 Million
4GLOBAL LS-01
F:HS9
$2.40 Million
Foresight VCT PLC
LSE:FTV
$2.40 Million
California Software Company Limited
NSE:CALSOFT
$2.40 Million
ModuLink Inc.
NASDAQ:MDLK
$2.38 Million
INTL SCHOOL AUGS.AG NA ON
F:9JK
$2.38 Million
Zotefoams PLC
LSE:ZTF
$2.38 Million
Orion Equities Ltd
AU:OEQ
$2.38 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Osteopore Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 432,603 to 306,220, a change of -126,383 (-29.2%).
  • Net loss of 3,352,436 reduced equity.
  • Share repurchases of 109,568 reduced equity.
  • New share issuances of 3,115,824 increased equity.
  • Other comprehensive income increased equity by 155,933.
  • Other factors increased equity by 63,864.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income AU$-3.35 Million -1094.78%
Share Repurchases AU$109.57K -35.78%
Share Issuances AU$3.12 Million +1017.51%
Other Comprehensive Income AU$155.93K +50.92%
Other Changes AU$63.86K +20.86%
Total Change AU$- -29.21%

Book Value vs Market Value Analysis

This analysis compares Osteopore Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.79x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 AU$-0.04 AU$0.01 x
2017-12-31 AU$-0.05 AU$0.01 x
2018-12-31 AU$0.11 AU$0.01 x
2019-12-31 AU$1.54 AU$0.01 x
2020-12-31 AU$1.26 AU$0.01 x
2021-12-31 AU$0.69 AU$0.01 x
2022-12-31 AU$0.26 AU$0.01 x
2023-12-31 AU$0.01 AU$0.01 x
2024-12-31 AU$0.00 AU$0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Osteopore Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -1094.78%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -119.24%
  • • Asset Turnover: 0.90x
  • • Equity Multiplier: 10.24x
  • Recent ROE (-1094.78%) is below the historical average (-290.10%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 0.00% -475.06% 0.24x 0.00x AU$-837.13K
2017 0.00% -73.20% 1.75x 0.00x AU$-263.45K
2018 -20.56% -93.09% 0.17x 1.28x AU$-1.29 Million
2019 -80.29% -575.36% 0.10x 1.44x AU$-2.68 Million
2020 -21.63% -129.33% 0.15x 1.14x AU$-2.85 Million
2021 -67.39% -325.33% 0.19x 1.12x AU$-4.16 Million
2022 -200.09% -249.09% 0.47x 1.72x AU$-4.43 Million
2023 -1126.20% -219.72% 0.66x 7.73x AU$-4.92 Million
2024 -1094.78% -119.24% 0.90x 10.24x AU$-3.38 Million

Industry Comparison

This section compares Osteopore Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $109,989,035
  • Average return on equity (ROE) among peers: 6.38%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Osteopore Ltd (OSX) AU$-423.65K 0.00% N/A $2.39 Million
Austco Healthcare Ltd (AHC) $23.09 Million 10.08% 0.47x $88.83 Million
Ansell Ltd (ANN) $348.07 Million -0.39% 0.99x $2.69 Billion
Nanosonics Ltd (NAN) $94.30 Million 6.10% 0.16x $721.18 Million
SDI Ltd (SDI) $73.08 Million 10.03% 0.18x $103.62 Million
Trajan Group Holdings Ltd (TRJ) $11.39 Million 6.06% 1.69x $40.47 Million

About Osteopore Ltd

AU:OSX Australia Medical Instruments & Supplies
Market Cap
$2.39 Million
AU$3.38 Million AUD
Market Cap Rank
#29490 Global
#1738 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.03
All Time High
AU$15.65
About

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates spe… Read more